Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis and Roche’s Xolair for hives condition
Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis [...]
Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis [...]
Recipharm, working on Moderna’s COVID vaccine, boosts biologics presence with [...]
J&J lands Tremfya one-two punch in IBD with first ulcerative [...]
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; [...]
Organon CEO pins high hopes on upcoming Humira biosimilar launch [...]
GSK launches trade secrets case against former employee, ordering data [...]
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, [...]
As Johnson & Johnson fights for bankruptcy ploy in talc [...]
After FDA’s surprising about-face, Acadia revives Nuplazid’s expansion bid with [...]
Thermo Fisher dishes up $40M for Pennsylvania facility expansion, creating [...]